Povzetek
Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5[alpha]-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy.
Ključne besede
predklinične študije;klinična učinkovitost;varnostne težave;benign prostatic hyperplasia;medicinal plants;phytotherapy;saw palmetto;preclinical studies;clinical efficacy;safety issues;
Podatki
Jezik: |
Angleški jezik |
Leto izida: |
2021 |
Tipologija: |
1.02 - Pregledni znanstveni članek |
Organizacija: |
UL FFA - Fakulteta za farmacijo |
UDK: |
616.65-007.61 |
COBISS: |
86644739
|
ISSN: |
1420-3049 |
Št. ogledov: |
187 |
Št. prenosov: |
78 |
Ocena: |
0 (0 glasov) |
Metapodatki: |
|
Ostali podatki
Sekundarni jezik: |
Slovenski jezik |
Sekundarne ključne besede: |
Benigna prostatična hiperplazija;Zdravilne rastline;Fitoterapija; |
Vrsta dela (COBISS): |
Članek v reviji |
Komentar vira: |
V članku na koncu seznama avtorjev navedeno: "and on behalf of the OEMONOM" (datum opombe 17. 5. 2022). |
Strani: |
str. 1-32 |
Letnik: |
ǂVol. ǂ26 |
Zvezek: |
ǂiss. ǂ23 |
Čas izdaje: |
2021 |
DOI: |
10.3390/molecules26237141 |
ID: |
15337764 |